560 related articles for article (PubMed ID: 7963117)
1. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. The Guardian ATP 4210 Multicenter Investigators Group.
Wood MA; Stambler BS; Damiano RJ; Greenway P; Ellenbogen KA
J Am Coll Cardiol; 1994 Dec; 24(7):1692-9. PubMed ID: 7963117
[TBL] [Abstract][Full Text] [Related]
2. Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing.
Bennett MT; Leader N; Sapp J; Parkash R; Gardner M; Healey JS; Thibault B; Sterns L; Essebag V; Birnie D; Sivakumaran S; Nery P; Andrade JG; Krahn AD; Tang A
Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005921. PubMed ID: 29618476
[TBL] [Abstract][Full Text] [Related]
3. Shock Reduction With Antitachycardia Pacing Before and During Charging for Fast Ventricular Tachycardias in Patients With Implantable Defibrillators.
Dallaglio PD; Anguera I; Martínez Ferrer JB; Pérez L; Viñolas X; Porres JM; Fontenla A; Alzueta J; Martínez JG; Rodríguez A; Basterra N; Sabaté X
Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):709-717. PubMed ID: 29242102
[TBL] [Abstract][Full Text] [Related]
4. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study.
Anguera I; Dallaglio P; Martínez-Ferrer J; Rodríguez A; Alzueta J; Pérez-Villacastín J; Porres JM; Viñolas X; Fontenla A; Fernández-Lozano I; García-Alberola A; Sabaté X
J Cardiovasc Electrophysiol; 2015 Jul; 26(7):774-82. PubMed ID: 25916814
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.
J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator.
Wietholt D; Block M; Isbruch F; Böcker D; Borggrefe M; Shenasa M; Breithardt G
J Am Coll Cardiol; 1993 Mar; 21(4):885-94. PubMed ID: 8185728
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
[TBL] [Abstract][Full Text] [Related]
8. Association of Antitachycardia Pacing or Shocks With Survival in 69,000 Patients With an Implantable Defibrillator.
Strickberger SA; Canby R; Cooper J; Coppess M; Doshi R; John R; Connolly AT; Roberts G; Karst E; Daoud EG
J Cardiovasc Electrophysiol; 2017 Apr; 28(4):416-422. PubMed ID: 28128491
[TBL] [Abstract][Full Text] [Related]
9. Marked attenuation of shock burden by the use of antitachycardia pacing therapy in a patient with an implanted cardioverter-defibrillator.
Ganjehei L; Nazeri A; Massumi A; Razavi M
Tex Heart Inst J; 2012; 39(4):568-70. PubMed ID: 22949781
[TBL] [Abstract][Full Text] [Related]
10. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
[TBL] [Abstract][Full Text] [Related]
11. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.
Mitchell JD; Lee R; Garan H; Ruskin JN; Torchiana DF; Vlahakes GJ
J Thorac Cardiovasc Surg; 1993 Mar; 105(3):453-62; discussion 462-3. PubMed ID: 8445925
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
13. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
Bardy GH; Yee R; Jung W
J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
[TBL] [Abstract][Full Text] [Related]
14. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease.
Wathen MS; Sweeney MO; DeGroot PJ; Stark AJ; Koehler JL; Chisner MB; Machado C; Adkisson WO;
Circulation; 2001 Aug; 104(7):796-801. PubMed ID: 11502705
[TBL] [Abstract][Full Text] [Related]
15. Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy.
Schukro C; Leitner L; Siebermair J; Pezawas T; Stix G; Kastner J; Schmidinger H
Int J Cardiol; 2013 Sep; 167(6):3006-10. PubMed ID: 23017814
[TBL] [Abstract][Full Text] [Related]
16. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
[TBL] [Abstract][Full Text] [Related]
17. Antitachycardia pacing reduces appropriate and inappropriate shocks in children and congenital heart disease patients.
Kalra Y; Radbill AE; Johns JA; Fish FA; Kannankeril PJ
Heart Rhythm; 2012 Nov; 9(11):1829-34. PubMed ID: 22766560
[TBL] [Abstract][Full Text] [Related]
18. Arrhythmic episodes in patients implanted with a cardioverter-defibrillator - results from the Prospective Study on Predictive Quality with Preferencing PainFree ATP therapies (4P).
Regoli F; Graf D; Schaer B; Duru F; Ammann P; Stefano LMDS; Naegli B; Burri H; Zbinden R; Krasniqi N; Fromer M;
BMC Cardiovasc Disord; 2019 Jun; 19(1):146. PubMed ID: 31208342
[TBL] [Abstract][Full Text] [Related]
19. Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators.
Sivagangabalan G; Chik W; Zaman S; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P
Am J Cardiol; 2013 Oct; 112(8):1153-7. PubMed ID: 23891430
[TBL] [Abstract][Full Text] [Related]
20. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.
Kleemann T; Strauss M; Kouraki K; Zahn R
Europace; 2015 Jul; 17(7):1068-75. PubMed ID: 25687746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
